Astromech, which uses genomic data to build predictive AI models of biological change, raised $20M at a $3.8B valuation, bringing its total funding to $60M (Dean Takahashi/GamesBeat)

Astromech, a company that leverages genomic data to construct predictive AI models for biological changes, recently secured $20M in funding. This latest investment values the company at $3.8B and increases its total funding to $60M. The news was reported by Dean Takahashi for GamesBeat, highlighting Astromech's continued growth in the field of AI and genomics.